These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28624548)

  • 21. 11β-HSD2 SUMOylation Modulates Cortisol-Induced Mineralocorticoid Receptor Nuclear Translocation Independently of Effects on Transactivation.
    Jiménez-Canino R; Lorenzo-Díaz F; Odermatt A; Bailey MA; Livingstone DEW; Jaisser F; Farman N; Alvarez de la Rosa D
    Endocrinology; 2017 Nov; 158(11):4047-4063. PubMed ID: 28938454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortisol, 11beta-hydroxysteroid dehydrogenases, and hypertension.
    van Uum SH; Lenders JW; Hermus AR
    Semin Vasc Med; 2004 May; 4(2):121-8. PubMed ID: 15478032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2.
    Kotelevtsev Y; Brown RW; Fleming S; Kenyon C; Edwards CR; Seckl JR; Mullins JJ
    J Clin Invest; 1999 Mar; 103(5):683-9. PubMed ID: 10074485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
    Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH
    J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.
    Diederich S; Eigendorff E; Burkhardt P; Quinkler M; Bumke-Vogt C; Rochel M; Seidelmann D; Esperling P; Oelkers W; Bähr V
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5695-701. PubMed ID: 12466373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Juvenile hypertension, the role of genetically altered steroid metabolism.
    Ferrari P; Bianchetti M; Frey FJ
    Horm Res; 2001; 55(5):213-23. PubMed ID: 11740142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apparent mineralocorticoid excess.
    Benediktsson R; Edwards CR
    J Hum Hypertens; 1994 May; 8(5):371-5. PubMed ID: 8064785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension.
    Glorioso N; Filigheddu F; Parpaglia PP; Soro A; Troffa C; Argiolas G; Mulatero P
    Eur Heart J; 2005 Mar; 26(5):498-504. PubMed ID: 15618035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
    Kratschmar DV; Vuorinen A; Da Cunha T; Wolber G; Classen-Houben D; Doblhoff O; Schuster D; Odermatt A
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):129-42. PubMed ID: 21236343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taxifolin inhibits rat and human 11β-hydroxysteroid dehydrogenase 2.
    Wu C; Cao S; Hong T; Dong Y; Li C; Wang Q; Sun J; Ge RS
    Fitoterapia; 2017 Sep; 121():112-117. PubMed ID: 28709706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients.
    Henschkowski J; Stuck AE; Frey BM; Gillmann G; Dick B; Frey FJ; Mohaupt MG
    Am J Hypertens; 2008 Jun; 21(6):644-9. PubMed ID: 18443572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by diuretics and the renin-angiotensin-aldosterone axis.
    Ricketts ML; Stewart PM
    Clin Sci (Lond); 1999 Jun; 96(6):669-75. PubMed ID: 10334975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
    Tomlinson JW; Stewart PM
    Best Pract Res Clin Endocrinol Metab; 2001 Mar; 15(1):61-78. PubMed ID: 11469811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in nasal polyp-derived epithelial cells and its possible contribution to glucocorticoid activation in nasal polyp.
    Kook JH; Kim HJ; Kim KW; Park SJ; Kim TH; Lim SH; Kang SH; Lee SH
    Am J Rhinol Allergy; 2015; 29(4):246-50. PubMed ID: 26163245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in the study of 11β-Hydroxysteroid dehydrogenase type 2 (11β-HSD2)Inhibitors.
    Zhou C; Ye F; Wu H; Ye H; Chen Q
    Environ Toxicol Pharmacol; 2017 Jun; 52():47-53. PubMed ID: 28366868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Species differences of 11beta-hydroxysteroid dehydrogenase type 2 function in human and rat term placenta determined via LC-MS/MS.
    Heussner K; Ruebner M; Huebner H; Rascher W; Menendez-Castro C; Hartner A; Fahlbusch FB; Rauh M
    Placenta; 2016 Jan; 37():79-84. PubMed ID: 26654513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut feelings about bacterial steroid-17,20-desmolase.
    Ly LK; Doden HL; Ridlon JM
    Mol Cell Endocrinol; 2021 Apr; 525():111174. PubMed ID: 33503463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection and optimization of MCF-7 cell line for screening selective inhibitors of 11beta-hydroxysteroid dehydrogenase 2.
    Kim CH; Cho YS
    Cell Biochem Funct; 2010 Aug; 28(6):440-7. PubMed ID: 20629036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uninephrectomy reduces 11β-hydroxysteroid dehydrogenase type 1 and type 2 concomitantly with an increase in blood pressure in rats.
    Lauterburg M; Escher G; Dick B; Ackermann D; Frey FJ
    J Endocrinol; 2012 Sep; 214(3):373-80. PubMed ID: 22739210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foetal and placental 11β-HSD2: a hub for developmental programming.
    Cottrell EC; Seckl JR; Holmes MC; Wyrwoll CS
    Acta Physiol (Oxf); 2014 Feb; 210(2):288-95. PubMed ID: 24330050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.